Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

Direct Payment

$150,000.00

The neurobiology of clinical placebo in chronic pain patients

EF 2012-13

Résumé
This project proposes to study the brain circuitry of the placebo effect in patients suffering from chronic pain using randomized double blind clinical trials (RCT) combined with brain imaging. While previous studies have revealed the brain networks involved in the experimental placebo response in healthy individuals, the neural basis of the clinical placebo response underlying sustainable and long lasting relief of chronic pain observed in the setting of clinical studies remains unknown. It is currently very difficult, if not impossible, to dissociate the effectiveness of a treatment independently from the placebo effect in clinical trials. Recent studies conducted in Dr Apkarian's laboratory suggest that brain-imaging techniques could accurately predict the patients' propensity to respond to clinical placebo. Building on these findings, the present project aims at dissociating the neurobiological placebo response from the NSAIDs response (naproxen 500mg) in a treatment of chronic back pain utilizing the setting of a RCT. Being able to identify a priori placebo responders from non-responders will permit to dissociate the actual effect of the pharmacological response independently from the placebo response in the treatment. The overall objectives of this project are (i) identifying brain markers predicting the placebo propensity in a large sample of chronic pain patients and (ii) dissociating the placebo effect from the active treatment, and (iii) determining the importance of the placebo response in the treatment of chronic pain. This project is therefore novel and important for better assessing drug effectiveness in RCT and improving the safety of the patients by introducing the opportunity of using the placebo treatment to better manage chronic pain by reducing exposure to undesired side effects that all active treatments invariably impart to recipients.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Illinois, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
281109
Name
Vachon-Presseau Etienne
Region
Illinois
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Health systems / services
Prcname2
Fellowships - Post-PhD
Projecttitle
The neurobiology of clinical placebo in chronic pain patients
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Brain Markers; Chronic Pain Treatment; Clinical Placebo Response; Neuroimaging; Pain; Randomized Double Blind Clinical Trials
Abstract
This project proposes to study the brain circuitry of the placebo effect in patients suffering from chronic pain using randomized double blind clinical trials (RCT) combined with brain imaging. While previous studies have revealed the brain networks involved in the experimental placebo response in healthy individuals, the neural basis of the clinical placebo response underlying sustainable and long lasting relief of chronic pain observed in the setting of clinical studies remains unknown. It is currently very difficult, if not impossible, to dissociate the effectiveness of a treatment independently from the placebo effect in clinical trials. Recent studies conducted in Dr Apkarian's laboratory suggest that brain-imaging techniques could accurately predict the patients' propensity to respond to clinical placebo. Building on these findings, the present project aims at dissociating the neurobiological placebo response from the NSAIDs response (naproxen 500mg) in a treatment of chronic back pain utilizing the setting of a RCT. Being able to identify a priori placebo responders from non-responders will permit to dissociate the actual effect of the pharmacological response independently from the placebo response in the treatment. The overall objectives of this project are (i) identifying brain markers predicting the placebo propensity in a large sample of chronic pain patients and (ii) dissociating the placebo effect from the active treatment, and (iii) determining the importance of the placebo response in the treatment of chronic pain. This project is therefore novel and important for better assessing drug effectiveness in RCT and improving the safety of the patients by introducing the opportunity of using the placebo treatment to better manage chronic pain by reducing exposure to undesired side effects that all active treatments invariably impart to recipients.
Competitiondate
201302
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vachon-Presseau, Etienne
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~